Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28646635 | 0.86 | CA2 (0.36) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL3360175 | 0.80 | CA2 (0.42) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL2422013 | 0.78 | ALDH1A1 (0.45) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL16908421 | 0.78 | CYP2C19 (0.42) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL9011114 | 0.78 | ALDH1A1 (0.47) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL5643653 | 0.76 | CA2 (0.39) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL30538382 | 0.76 | CA2 (0.44) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL10523972 | 0.76 | CA2 (0.44) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL2533300 | 0.75 | CA2 (0.36) | CA2ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21950874 | 0.75 | MEN1 (0.37) | ALDH1A1TSHRTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118995118-A | Polyurethane anchoring agent and preparation method thereof | 巴斯夫浩珂矿业化学（中国）有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-2220154-B1 | C7-C12 SECONDARY ALCOHOL ESTERS OF CYCLOHEXANOIC ACID | EXXONMOBIL CHEM PATENTS INC (US) | 2014-06-18 | — | — | EP | claimed |
| US-8669311-B2 | C7—C12 secondary alcohol esters of cyclohexanoic acid | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-03-11 | — | — | US | claimed |
| US-20100305250-A1 | C7-C12 Secondary Alcohol Esters of Cyclohexanoic Acid | EXXONMOBIL CHEMICAL PATENTS INC. | 2010-12-02 | — | — | US | claimed |
| EP-2220154-A1 | C7-C12 SECONDARY ALCOHOL ESTERS OF CYCLOHEXANOIC ACID | ExxonMobil Chemical Patents Inc. (US) | 2010-08-25 | — | — | EP | claimed |
| WO-2009070398-A1 | C7-C12 SECONDARY ALCOHOL ESTERS OF CYCLOHEXANOIC ACID | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-06-04 | — | — | WO | claimed |
| US-12570883-B2 | Sealant composition | DOW SILICONES CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4077576-B1 | SEALANT COMPOSITION | DOW SILICONES CORP (US) | 2026-01-14 | — | — | EP | disclosed |
| CN-115843304-A | Plasticizer composition and vinyl chloride resin composition comprising same | 韩华思路信(株) | 2023-03-24 | — | — | CN | disclosed |
| US-20230035408-A1 | SEALANT COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2023-02-02 | — | — | US | disclosed |
| US-20230022605-A1 | SEALANT COMPOSITION | DOW CHEMICAL (CHINA) INVESTMENT COMPANY LIMITED (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-4077576-A1 | SEALANT COMPOSITION | Dow Silicones Corporation (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-4077577-A1 | SEALANT COMPOSITION | Dow Silicones Corporation (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-2049254-B1 | PROCESS FOR REGENERATING RUTHENIUM CATALYSTS FOR THE RING HYDROGENATION OF PHTHALATES | BASF SE (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-2049254-A2 | PROCESS FOR REGENERATING RUTHENIUM CATALYSTS FOR THE RING HYDROGENATION OF PHTHALATES | BASF SE (DE) | 2009-04-22 | — | — | EP | disclosed |
| EP-2049253-A2 | PROCESS FOR REGENERATING RUTHENIUM CATALYSTS WHICH ARE SUITABLE FOR HYDROGENATION | BASF SE (DE) | 2009-04-22 | — | — | EP | disclosed |
| EP-1899051-A2 | CATALYST AND METHOD FOR HYDROGENATING ORGANIC COMPOUNDS CONTAINING HYDROGENABLE GROUPS | BASF SE (DE) | 2008-03-19 | — | — | EP | disclosed |
| WO-2008015103-A2 | PROCESS FOR REGENERATING RUTHENIUM CATALYSTS WHICH ARE SUITABLE FOR HYDROGENATION | BASF SE (DE) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008015135-A2 | PROCESS FOR REGENERATING RUTHENIUM CATALYSTS FOR THE RING HYDROGENATION OF PHTHALATES | BASF SE (DE) | 2008-02-07 | — | — | WO | disclosed |
| WO-2006136541-A2 | CATALYST AND METHOD FOR HYDROGENATING ORGANIC COMPOUNDS CONTAINING HYDROGENABLE GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570883-B2 | Sealant composition | SSRP1, ZRANB2, RCC1 | CA2 626/4885ALDH1A1 1587/4885CYP3A4 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.